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Abstract
Introduction The limited ability of current treatments to control
metastasis and the proposed antitumor properties of specific
nutrients prompted us to examine the effect of a specific
formulation (nutrient supplement [NS]) of lysine, proline,
arginine, ascorbic acid, and green tea extract in vivo on the
development of N-methyl-N-nitrosourea (MNU)-induced
mammary tumors in rats.
Methods A single intraperitoneal dose of MNU was injected into
each of 20 female Sprague–Dawley rats (aged 50 days) to
induce tumors. Two weeks after MNU treatment, a time by which
the animals had recovered from MNU-induced toxicity, the rats
were divided into two groups. Rats in group 1 (n = 10) were fed
Purina chow diet, whereas those in group 2 (n = 10) were fed
the same diet supplemented with 0.5% NS. After a further 24
weeks, the rats were killed and tumors were excised and
processed.
Results NS reduced the incidence of MNU-induced mammary
tumors and the number of tumors by 68.4%, and the tumor
burden by 60.5%. The inhibitory effect of NS was also reflected
by decreased tumor weight; the tumor weights per rat and per
group were decreased by 41% and 78%, respectively. In
addition, 30% of the control rats developed ulcerated tumors, in
contrast to 10% in the nutrient supplemented rats.
Conclusion These findings suggest that the specific
formulation of lysine, proline, arginine, ascorbic acid, and green
tea extract tested significantly reduces the incidence and
growth of MNU-induced mammary tumors, and therefore has
strong potential as a useful therapeutic regimen for inhibiting
breast cancer development.
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Introduction
Breast cancer is the most prevalent cancer in women
worldwide, excluding nonmelanoma skin cancer, and is the
second leading cause of cancer deaths in women (follow-
ing lung cancer) [1]. Once metastasis has occurred, the
survival rate is drastically reduced to a median of 2–3 years;
therapy is then aimed at controlling symptoms, prolonging
survival and improving quality of life [2]. Unfortunately, the
diagnostic criteria currently used to stage breast cancer
often yield inaccurate findings with regard to metastasis.
Analyses of bone marrow samples (not a routine proce-
dure) have revealed the presence of disseminated cells in
up to 40% of primary breast cancer patients without any
clinical or histopathologic signs of metastasis. Circulating
breast cancer cells in bone marrow are indicative of metas-
tasis to such sites as bone, lung, and liver [3].
Cancer cells form tumors and spread by degrading the
extracellular matrix (ECM) through various matrix metallo-
proteinases (MMPs). The activity of these enzymes corre-
lates with the aggressiveness of tumor growth and the
invasiveness of the cancer. Rath and Pauling [4] postulated
that nutrients such as lysine and ascorbic acid could act as
natural inhibitors of ECM proteolysis, and as such they have
ECM = extracellular matrix; EGCG = epigallocatechin-3-gallate; MMP = matrix metalloproteinase; MNU = N-methyl-N-nitrosourea; NS = nutrient 
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the potential to inhibit tumor growth and expansion. These
nutrients may exert their antitumor effect through inhibiting
MMPs and strengthening the connective tissue surround-
ing cancer cells (a 'tumor encapsulating' effect). Addition-
ally, it has been suggested that, through inhibition of
hyaluronidase, ascorbic acid can prevent metastases by
preventing degradation of the ground substance surround-
ing the tumor.
In a previous study [5] we demonstrated the antiprolifera-
tive and anti-invasive potential of a specific formulation
(nutrient supplement [NS]) of lysine, ascorbic acid, proline,
and green tea extract on human breast cancer (MDA-MB
231), colon cell cancer (HCT 116), and melanoma
(A2058) cell lines. NS also suppressed the growth of these
tumors, without any adverse effects, in nude mice. In the
present study we investigated the inhibitory effect of NS in
vivo  on development of N-methyl-N-nitrosourea (MNU)-
induced mammary tumors in rats.
Methods
Animals
On arrival at our laboratory, 40-day-old pathogen free
female Sprague–Dawley rats (Simonsen Laboratories, Gil-
roy, CA, USA) were housed in solid bottom cages with
corncob bedding, at 22°C and 50% humidity, with a 12-
hour light–dark cycle. The rats had free access to water
and Purina rat chow diet. All animals were cared for in
accordance with institutional guidelines for the care and
use of experimental animals.
Experiments
At day 50, all rats (n = 20) received a single dose of MNU
50 mg/kg intraperitoneally. (MNU, reagent grade, was
obtained from Sigma, St. Louis, MO, USA). Two weeks
after MNU treatment, a time by which the animals had
recovered from MNU-induced toxicity, the rats were divided
into two groups. Rats in group 1 (n = 10) were fed a pellet
Purina chow diet (Purina Mills, Richmond, IN, USA),
whereas those in group 2 (n = 10) were fed a pellet diet
custom prepared by Purina containing the same diet but
supplemented with 0.5% of the NS.
Body weight and diet consumption of the rats were moni-
tored every week. Beginning 6 weeks after MNU adminis-
tration, the rats were palpated every week for evidence of
tumors. Dimensions (length × width) of the tumors were
measured using a digital caliper, and the tumor burden was
calculated using the following formula: 0.5 × length ×
width. Twenty-four weeks later the rats were killed by car-
bon dioxide asphyxiation and skinned; tumors were excised
and a detailed necropsy was performed on each rat. Loca-
tion, weight, and dimensions of excised mammary tumors
were recorded. Tumors were processed for histologic
examination, using criteria described by Russo and cow-
orkers [6]. Briefly, histopathologic criteria used to deter-
mine malignancy were loss of tubular–alveolar pattern of
the normal mammary gland; presence of large epithelial
cells with increased nuclear–cytoplasmic ratio; stromal
response by fibrosis and inflammatory cell infiltration; and
necrosis and hemorrhage.
Table 1
Tumor incidence and multiplicity for control and supplemented rats
Rat group 0 Tumors 1 Tumor 2 Tumors 3 Tumors 4 Tumors 5 Tumors Total number of 
Tumors
Control group (n =  1 0 )143011 1 9
Supplemented group (n =  1 0 ) 541000 6
Table 2
Mean tumor burden per rat and tumor burden per group
Rat group Total tumor burden per group Mean tumor burden per rat
Control group (n = 10; 19 tumors) 183.2 cm2 18.3 ± 1.3 cm2
Supplemented group (n = 10; six tumors) 72.2 cm2 7.22 ± 1.8 cm2
The mean tumor burden per rat is expressed as mean ± standard deviation. The differences between groups were significant (P < 0.0001).Available online http://breast-cancer-research.com/content/7/3/R291
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Composition of the nutrient supplement
Stock solution of the NS (total weight 4.2 g) is composed
of the following: 700 mg vitamin C (as ascorbic acid and as
magnesium, calcium, and palmitate ascorbate), 1000 mg L-
lysine, 750 mg L-proline, 500 mg L-arginine, 200 mg N-
acetyl cysteine, 1000 mg standardized green tea extract,
30 mg selenium, 2 mg copper, and 1 mg manganese.
Green tea extract, derived from green tea leaves, was
obtained from US Pharma Lab (Newark, NJ, USA). The cer-
tificate of analysis indicates the following characteristics:
total polyphenol 80%, catechins 60%, epigallocatechin-3-
gallate (EGCG) 35%, and caffeine 1.0%.
Statistical analysis
Results are expressed as means ± standard deviation for
the groups. Data were analyzed by independent samples t-
test.
Results
Tumor incidence and multiplicity
Of the 10 rats in the control group, nine developed at least
one tumor; the total number of tumors in that group was 19.
In contrast, five of the supplemented rats were completely
free of tumors, and the total number of tumors in that group
was six. As shown in Table 1, treatment with nutrients sig-
nificantly reduced the incidence of MNU-induced mammary
tumors and the number of tumors per rat (tumor multiplicity)
by 68.4%.
Tumor burden
Tumor burden (tumor length × width × 0.5) in MNU-
induced mammary tumors was inhibited by nutrient synergy
by 60.5% (P = 0.0001) as shown in Table 2. The mean
tumor burden per rat for the control group was 18.3 cm2, in
contrast to a mean tumor burden of 7.22 cm2 in the nutrient
supplemented group (P < 0.0001).
Tumor weight
The inhibitory effect of NS was also reflected in a
decreased tumor weight (Table 3). For example, tumor
weight per rat and per group were decreased by 41% and
78%, respectively (P = 0.0001). The mean tumor weight
per rat in the control group (4.34 g) was significantly
greater (P = 0.002) than that in the supplemented group
(0.97 g). The mean individual tumor weight also differed
significantly between groups.
Rat growth
We observed no significant difference (P = 0.62) in growth
between groups over the period of study (Table 4).
Tumor histology
The tumors that developed in the control group rats were
all adenocarcinomas (Fig. 1). The lesions are rather cellular
and consist of a proliferation of epithelial and stromal com-
ponents; the epithelial elements range from reactive to
malignant in nature. The majority of the tumor is adenoma-
tous and exhibits features of florid sclerosing adenosis
admixed with low-grade ductal carcinoma in situ. Focal
areas exhibit features diagnostic of adenocarcinoma,
including increased mitotic index, atypical mitotic figures,
moderate to severe cytologic atypia, coagulative tumor cell
necrosis, and jagged infiltrating margins. The lesion is well
circumscribed in areas and is associated with a brisk host
response composed of reactive stromal cells and a mixed
inflammatory infiltrate. Angiogenesis is much more promi-
nent than in the adenomas in the supplemented rats. In
contrast, the tumors that developed in the nutrient supple-
mented rats were all adenomas (Fig. 2). The lesion is
moderately cellular and consists of epithelial and stromal
components. The overall cytoarchitectural features are
indicative of a fibroepithelial lesion, such as a fibroade-
noma. The epithelial cells exhibit mild to moderate cytologic
Table 3
Mean tumor weight per rat and per group
Rat group Total tumor weight per group Mean tumor weight per rat Mean individual tumor weight
Control group (n = 10; 19 tumors) 43.38 g 4.34 ± 1.5 g 2.3 ± 0.8 g
Supplemented group (n = 10; six tumors) 9.63 g 0.97 ± 2.6 g 0.73 ± 0.5 g
Significance P = 0.002 P = 0.002
Table 4
Mean growth of control and supplemented rats
Rat group Mean initial weight Mean end weight
Control group (n = 10) 143 ± 4 g 422 ± 24 g
Supplemented group (n = 10) 148 ± 5 g 415 ± 37 gBreast Cancer Research    Vol 7 No 3    Roomi et al.
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atypia and a low mitotic index. The lesion is well circum-
scribed and exhibits prominent papillary architecture. The
stromal and vascular proliferation is much less than that
seen in the adenocarcinoma.
Discussion
We chose to study the effect of a mixture of nutrients on
MNU-induced mammary tumors in the Sprague–Dawley rat
model because the histologic structure of mammary gland
tumors in this animal closely resembles that of human mam-
mary tumors. Induction of mammary carcinomas by MNU in
female rats is one of the most frequently used animal mod-
els for the investigation of breast carcinogenesis and mam-
mary tumor treatment [7-9]. In contrast to mouse lesions,
which are primarily alveolar, rat mammary tumors are pre-
dominantly ductal, as are human ones [9], and the most
highly malignant rat tumors share some features with
human intraductal and infiltrating ductal carcinomas [8]. It
has been reported that the MNU model has several advan-
tages, such as reliability of tumor induction, organ site spe-
cificity, tumor of ductal origin and predominantly
carcinomatous histopathologic characterization, and the
ability to examine tumor initiation and promotion processes
[10]. Generally MNU-induced mammary carcinomas are
aggressive and locally invasive.
The results of the present study demonstrate significant
inhibition of mammary tumor incidence and multiplicity in
Sprague–Dawley female rats by supplementation with
0.5% of the nutrient mixture (which contains ascorbic acid,
lysine, proline, and epigallocatechin gallate). Furthermore,
rats that consumed the nutrient supplemented diet exhib-
ited decreased growth of MNU-induced mammary tumors
and tumor burden compared with rats fed control diets. The
numerous tumors in the control rats not only were larger but
also had characteristics diagnostic of adenocarcinoma,
including increased mitotic index and prominent angiogen-
esis, in contrast to the few, small adenomas with low mitotic
index found in the nutrient treated rats.
Although the mechanism underlying the reduced tumor size
in tumor bearing rats was not identified in this experiment,
these findings are consistent with our previous in vitro stud-
ies that demonstrated significant inhibition of angiogenic
and invasive parameters in human breast cancer cell lines
MDA MB-231 and MCF-7. Expression of vascular endothe-
lial growth factor, MMP secretion, and matrix invasion by
these breast cancer cells were dramatically inhibited in a
dose-dependent manner by the combined effect of the
nutrients in this mixture [11]. Matrix invasion can be control-
led by inhibition of MMP expression, as well as by increas-
ing connective tissue strength and stability, contributing to
the 'encapsulation' of the tumor. Optimization of synthesis
and structure of collagen fibrils depends upon hydroxyla-
tion of proline and lysine residues in collagen fibers. It is
well known that ascorbic acid is essential for the
hydroxylation of these amino acids and that it regulates col-
lagen synthesis at the transcriptional level.
Inhibitory and chemopreventive effects in malignant cell
lines of some of the individual nutrients composing the NS
have been reported in both clinical and experimental stud-
ies. Ascorbic acid has been shown to have growth inhibi-
tory and antineoplastic activities in human mammary tumor
bearing mice [12]. In addition, low levels of ascorbic acid
have been reported in cancer patients [13-15]. Green tea
extract is another potent anticancer agent that has been
reported to have a growth inhibitory effect against certain
human cancer cell lines, especially breast cancer [16-18].
For example, both in vitro and animal studies of the effect
of green tea extract on breast cancer revealed suppressed
xenograft size and tumor vessel density and suppression of
cell proliferation [19].
Furthermore, studies conducted before the clinical onset of
breast cancer found that increased green tea consumption
was associated with improved prognosis in stage I and II
breast cancers, as well as decreased numbers of axillary
lymph node metastases in premenopausal women, sug-
Figure 1
Histological slides showing examples of N-methyl-N-nitrosourea  induced mammary tumors in Sprague–Dawley rats fed the control diet  (hematoxylin and eosin) Histological slides showing examples of N-methyl-N-nitrosourea 
induced mammary tumors in Sprague–Dawley rats fed the control diet 
(hematoxylin and eosin). Original magnifications: (a) 100× and (b) 
200×.
Figure 2
Histological slides showing examples of N-methyl-N-nitrosourea  induced mammary tumors in Sprague–Dawley rats fed the supple- mented diet (hematoxylin and eosin) Histological slides showing examples of N-methyl-N-nitrosourea 
induced mammary tumors in Sprague–Dawley rats fed the supple-
mented diet (hematoxylin and eosin). Original magnifications: (a) 100× 
and (b) 200×.Available online http://breast-cancer-research.com/content/7/3/R291
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gesting significant chemopreventative potential [20]. Utiliz-
ing the Sprague–Dawley rat model, researchers showed
that EGCG reduced tumor burden and number of invasive
tumors, and drastically increased the mean latency to the
initial tumor in mammary tumor bearing rats [21].
Our previous in vitro studies demonstrated that the anti-
cancer effect of a mixture of ascorbic acid, proline, lysine,
and EGCG on several cancer cell lines in tissue culture
studies was greater than that of the individual nutrients [5].
Furthermore, in contrast to chemotherapy, which causes
indiscriminate cellular and ECM damage, previous studies
showed that cell morphology was not affected even at the
highest concentrations of this nutrient mixture, demonstrat-
ing that this formulation is safe to cells.
Conclusion
The results of the present study showed that the specific
nutrient mixture of lysine, proline, arginine, ascorbic acid,
and green tea extract tested significantly inhibited the inci-
dence, as well as the growth, of MNU-induced mammary
tumors. Although clinical trials are necessary to assess the
antitumor ability of the tested nutrient mixture on cancer
patients, the results of this study suggest strong potential
for its use as a therapeutic regimen for inhibiting breast
cancer development.
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